Zu Beginn der Hypertonietherapie stets aufs Kreatinin achten!

MMW Fortschr Med. 2021 Apr;163(8):24-26. doi: 10.1007/s15006-021-9848-0.
[Article in German]
No abstract available

Publication types

  • Review
  • Comment

MeSH terms

  • Antihypertensive Agents / therapeutic use
  • Cardiovascular Diseases* / drug therapy
  • Cohort Studies
  • Creatinine
  • Heart Disease Risk Factors
  • Humans
  • Hypertension* / drug therapy
  • Risk Factors

Substances

  • Antihypertensive Agents
  • Creatinine